FULC Stock Crashes After Hours: What Investors Need To Know
Fulcrum Therapeutics stock plunged after the company discontinued its lead sickle cell disease drug following FDA concerns.
Open original sourceLoading market dashboard
Fulcrum Therapeutics stock plunged after the company discontinued its lead sickle cell disease drug following FDA concerns.
Open original source